Filing Details

Accession Number:
0001209191-17-046854
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-01 10:55:44
Reporting Period:
2017-07-31
Filing Date:
2017-08-01
Accepted Time:
2017-08-01 10:55:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
316011 Lilly Endowment Inc 2801 North Meridian Street
Indianapolis IN 46208-0068
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-07-31 216,521 $83.08 124,049,283 No 4 S Direct
Common Stock Disposition 2017-07-31 3,479 $83.68 124,045,804 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.65 to $83.64, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.65 to $83.75, inclusive.